Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study
- Citation:
- Naguib, M. J., and A. I. A. Makhlouf,
"Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study",
drug delivery, vol. 28, issue 1, pp. 1301-1311, 2021.
